Research Type: Extramural
Recent research has found that androgens (such as testosterone) can activate an important anti-cancer immune response in prostate cancer cells.
Professor Kavallaris and her team aim to dramatically reduce duration of tumour testing programs, with direct benefits to patients from more rapid adoption of recommended treatments.
A/Professor Croucher and his team are investigating new treatment options for triple-negative breast cancers that have spread.
Dr Wang will investigate and detail how leukaemic stem cells are able to survive and renew.
A/Professor Ziegler will test if a new drug combination can switch off the overactive molecular pathway and halt cancer progression in the most aggressive childhood brain tumours.
A/Prof Swarbrick and his team will study multiple solid cancers that have a range of responses to immunotherapy. The team will identify which types of stromal cells block immune responses to cancer and how they do this.
A/Professor Wang and her team will develop a test to monitor treatment response and watch for the early signs of treatment failure.
Dr Blancafort and her team will develop a test to detect a gene prolific in aggressive forms of breast cancer and identify new treatment targets.
Prof Price is investigating how new imaging technology could be used to enhance radiotherapy effectiveness in solid cancers.